ÂÜÀòÂÒÂ×

Ken Solovay is the Chief Operating Officer at ILiAD Biotechnologies since April 2012. Prior to this role, Ken held similar positions at Seedlings Life Science Ventures, ScrubStorm, and Aspiration Medical Technology. Ken's extensive experience includes working at GMP Companies and Cordis, a Johnson & Johnson Company, where Ken managed various product development projects. Ken holds a Master of Science in Biomedical Engineering from the University of Alabama at Birmingham and a Bachelor of Science in Materials Science & Engineering from the University of Florida.